On Friday, Zimmer Biomet Holdings Inc (NYSE:ZBH)’s shares declined -0.74% to $104.07.
Zimmer Biomet Holdings, Inc. (ZBH) stated financial results for the quarter ended June 30, 2015. The Company stated second quarter net sales of $1.17 billion, a decrease of 1.3% stated and an enhance of 5.7% constant currency contrast to the second quarter of 2014. Attained revenue from Biomet amounted to $60 million, a contribution of 5.0% of the constant currency growth rate. Standalone Zimmer recorded constant currency growth in the quarter of 0.7%. Stated net loss per share for the quarter was $(0.91) and adjusted earnings per share were $1.59, an enhance of 0.6% over the preceding year period.
Net loss for the second quarter was $(158.0) million on a stated basis. On an adjusted basis, net earnings raised 2.8% over the preceding year period, to $278.7 million. Operating cash flow for the second quarter was $186.8 million.
During the quarter, the Company recorded certain non-recurring, pre-tax expenses, counting $465.0 million of charges regarding the Biomet merger and $89.6 million of special items and certain claims. Additionally, pre-tax amortization expense in the quarter was $34.9 million.
Also in the quarter, the Company paid $37.4 million in dividends and declared a second quarter dividend of $0.22 per share, comprising with the dividend declared for the preceding year period.
Zimmer Biomet Holdings, Inc., together with its auxiliaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. It offers orthopaedic reconstructive devices that restore function lost due to disease or trauma in joints comprising knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons for the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process.
Fortinet Inc (NASDAQ:FTNT)’s shares gained 0.34% to $47.74.
Fortinet (FTNT), the global leader in high-performance cyber security solutions, recently unveiled its new Cyber Threat Assessment program designed to provide organizations a detailed look into the type and number of cyber threats posing risks to their networks, yet are going undetected by their existing security solutions. This new offering is part of a broader effort by Fortinet and its FortiGuard Labs threat research team to integrate risk and advisory capabilities with its end-to-end security platform to provide customers greater insight into dynamically changing cyber risks that threaten their businesses.
Fortinet, Inc. provides cyber security solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and virtual appliances products that provide various integrated security and networking functions to protect data, applications, and users from network- and content-level security threats; FortiManager product family to manage the system configuration and security functions of multiple FortiGate devices from a centralized console; and the FortiAnalyzer product family, which enables the collection, analysis, and archiving of content and log data generated by its products.
At the end of Friday’s trade, Teradata Corporation (NYSE:TDC)‘s shares surged 1.39% to $37.11.
WANdisco (WAND.L), a leading provider of continuous-availability software for global enterprises to meet the challenges of Big Data, recently declared it had signed a record number of large global organizations as customers for its new Fusion product during the second quarter. All of these new customers are predictable to significantly expand their deployments during the coming months. The company attributes this rapid adoption to Fusion’s flexible, easy-to-deploy architecture that provides active-active replication across mixed storage environments counting Oracle BDA (ORCL), Cloudera, Hortonworks (HDP), EMC (EMC) and MapR.
The simplicity and interoperability of WANdisco Fusion has enabled new key partnerships with companies counting Oracle, Teradata (TDC) and Hortonworks and has assisted accelerate this rapid growth.
New customers comprised of some of the world’s largest financial service companies, retail, telecommunications and government organizations. The deals also covered wide geographies in Americas, Asia Pacific region and Europe demonstrating the global reach and sales organization of WANdisco.
Teradata Corporation provides analytic data platforms, marketing and analytic applications, and related services in the United States and internationally. Its analytic data platforms comprise software, hardware, and related business consulting and support services for data warehousing and big data analytics. The company’s products comprise Teradata Database Software that delivers near real-time intelligence; Teradata Workload-Specific Platforms; Teradata Aster Discovery Platform, which is pre-configured with Teradata Aster Database; Teradata Portfolio for Hadoop; and Teradata QueryGrid that provides access to analytics to various processing engines.
Eastman Chemical Company (NYSE:EMN), ended its Friday’s trading session with -0.24% loss, and closed at $78.40.
Brad Lich, Executive Vice President, Eastman Chemical Company (EMN), will address the Jeffries Industrials Conference in New York City on Aug. 11, 2015 at 8:00 a.m. ET.
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
